Literature DB >> 15848168

Heparanase processing by lysosomal/endosomal protein preparation.

Esti Cohen1, Ruth Atzmon, Israel Vlodavsky, Neta Ilan.   

Abstract

Heparanase is an endo-beta-glucuronodase involved in cleavage of heparan sulfate side chains, activity that is strongly implicated in cell dissemination associated with tumor metastasis and inflammation. Heparanase is first synthesized as a latent 65 kDa precursor that is converted into an active enzyme upon proteolytic processing. Previously, we have reported that elevation of the lysosomal pH results in complete inhibition of heparanase processing, suggesting that lysosomal protease(s) and acidic pH conditions are required for heparanase processing. Here, we adopted a cell fractionation approach and provide evidence that incubation of the pro-enzyme with lysosome/endosome, but not with cytoplasmic fractions resulted in processing and activation of the 65 kDa latent heparanase. Moreover, while the water soluble lysosome/endosome fraction exhibited no apparent processing activity, heparanase processing by the water insoluble lysosome/endosome membrane fraction was readily detected and exhibited the expected pH dependency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848168     DOI: 10.1016/j.febslet.2005.03.030

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity.

Authors:  Flonia Levy-Adam; Sari Feld; Victoria Cohen-Kaplan; Anna Shteingauz; Miriam Gross; Gil Arvatz; Inna Naroditsky; Neta Ilan; Ilana Doweck; Israel Vlodavsky
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

2.  Processing of heparanase is mediated by syndecan-1 cytoplasmic domain and involves syntenin and α-actinin.

Authors:  Anna Shteingauz; Neta Ilan; Israel Vlodavsky
Journal:  Cell Mol Life Sci       Date:  2014-05-01       Impact factor: 9.261

3.  Molecular characterization of arylsulfatase G: expression, processing, glycosylation, transport, and activity.

Authors:  Björn Kowalewski; Torben Lübke; Katrin Kollmann; Thomas Braulke; Thomas Reinheckel; Thomas Dierks; Markus Damme
Journal:  J Biol Chem       Date:  2014-08-18       Impact factor: 5.157

4.  A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

Authors:  Uri Barash; Victoria Cohen-Kaplan; Gil Arvatz; Svetlana Gingis-Velitski; Flonia Levy-Adam; Ofer Nativ; Ronen Shemesh; Michal Ayalon-Sofer; Neta Ilan; Israel Vlodavsky
Journal:  FASEB J       Date:  2009-12-09       Impact factor: 5.191

Review 5.  Heparanase: busy at the cell surface.

Authors:  Liat Fux; Neta Ilan; Ralph D Sanderson; Israel Vlodavsky
Journal:  Trends Biochem Sci       Date:  2009-09-03       Impact factor: 13.807

6.  Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy.

Authors:  Anna Shteingauz; Ilanit Boyango; Inna Naroditsky; Edward Hammond; Maayan Gruber; Ilana Doweck; Neta Ilan; Israel Vlodavsky
Journal:  Cancer Res       Date:  2015-08-06       Impact factor: 12.701

Review 7.  Heparanase: a target for drug discovery in cancer and inflammation.

Authors:  E A McKenzie
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

8.  A Phylogenetic analysis of Heparanase (HPSE) gene.

Authors:  Abjal Pasha Shaik; Abbas H Alsaeed; Asma Sultana
Journal:  Bioinformation       Date:  2012-05-15

Review 9.  Mammalian heparanase: what is the message?

Authors:  Veronique Vreys; Guido David
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

Review 10.  Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers.

Authors:  Elizabeth E Hull; McKale R Montgomery; Kathryn J Leyva
Journal:  Int J Mol Sci       Date:  2017-06-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.